CAR-T cell Therapy: Past Successes and Future Challenges

Shruti Thakur and Rachana
Additional contact information
Rachana: Department of Biotechnology, Jaypee Institute of Information Technology, India

Cancer Therapy & Oncology International Journal, 2018, vol. 10, issue 2, 23-25

Abstract: Cancer therapy in the last few decades has gone through immense changes in the treatment regimen. For the last years, the main formof treatment for any type of cancer were surgery, radiation and chemotherapy. These methods though the backbone of any cancer treatment do not help in advanced and relapsed cancer stages [1]. To develop therapies that could help patients in advanced stages of cancer, researchers developed targeted therapy in the form of monoclonal antibodies, and these were marketed for different types of cancer depending on the target they attack [2]. Some examples include imatinib (Gleecev) and trastuzumab (Herceptin), to name two. These drugs worked by honing in on specific molecular targets on cancer cells, becoming the standard of treatment for those cancers.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555783.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555783.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:10:y:2018:i:2:p:23-25

DOI: 10.19080/CTOIJ.2018.10.555783

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().